Illumina, Inc. has announced that it is partnering with the Center for Inherited Disease Research (CIDR) to use the Sentrix ® HumanHap300 BeadChip and Infinium™ Assay for a pilot study of Type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback